Differential expression and androgen regulation of the human selenium- binding protein gone hSP56 in prostate cancer cells

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3150-3153

  Yang, Meiheng ^a   Sytkowski, Arthur J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BINDING PROTEIN; GENE PRODUCT; SELENIUM;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SELENIUM DEFICIENCY;

ANDROGENS; BASE SEQUENCE; CARCINOMA; CARRIER PROTEINS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HEAT-SHOCK PROTEINS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; SELENIUM-BINDING PROTEINS; TACROLIMUS BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032527625     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. van Vleet, J. F., and Ferrans, V. J. Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans. Biol. Trace Elem. Res., 33: 1-21, 1992.
2. Combs, G. F., Jr., and Combs, S. The Role of Selenium in Nutrition. New York: Academic Press, 1986.
3. Shamberger, R. J., and Frost, D. V. Possible protective effect of selenium against human cancer. Can. Med. Assoc. J., 100: 682, 1969.
4. Schrauzer, G. N., and Thead, W. J. Interpretation of the methylene blue reduction test of human plasma and the possible cancer protecting effect of selenium. Experientia (Basel), 27: 1069-1071, 1971.
5. Ip, C. Selenium and experimental cancer. Ann. Clin. Res., 18: 22-29, 1986.
6. Willett, W. C., and Stampfer, M. J. Selenium and human cancer. Acta Pharm. Toxicol., 59 (Suppl. 7): 240-247, 1986.
7. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K., and Karvonen, M. J. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer (Phila.), 60: 145-148, 1987.
8. Salonen, J. T., Alfthan, G., Huttunen, J. K., and Puska, P. Association between serum selenium and the risk of cancer. Am. J. Epidemiol., 120: 342-349, 1984.
9. Glattre, E., Thomassen, Y., Thoresen, S. O., Haldorsen, T., Glund-Larsen, P., Theodorsen, L., and Aaseth, J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int. J. Epidemiol., 18: 45-49, 1989.
10. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst. (Bethesda), 82: 864-868, 1990.
11. Clark, L. C., Combs, G. F., Tumbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Park, K., Sanders, B. B., Jr., Smith, C. L., and Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. J. Am. Med. Assoc., 276: 1957-1963, 1996.
12. Stadtman, T. C. Selenocysteine. Annu. Rev. Biochem., 65: 83-100, 1996.
13. Yasui, Y., Hasada, K., Yang, J. G., and Koiwai, O. Structure and organization of the gene encoding human selenoprotein. Gene, 175: 269-270, 1996.
14. Liu, S. Y., and Stadtman, T. C. Heparin-binding properties of selenium-containing thioredoxine reductase from HeLa cells and human lung adenocarcinoma cells. Proc. Natl. Acad. Sci. USA, 94: 6138-6141, 1997.
15. Simon, T. C., Cho, A., Tso, P., and Gordon, J. I. Suppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice. J. Biol. Chem., 272: 10652-10663, 1997.
16. Orlandi, P. A. Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J. Biol. Chem., 272: 4591-4599, 1997.
17. Bansal, M. P., Mukhopadhyay, T., Scott, J., Cook, R. G., Mukhopadhyay, R., and Medina, D. DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer prevention. Carcinogenesis (Lond.), 11: 2071-2073, 1990.
18. Lanfear, J., Fleming, J., Walker, M., and Harrison, P. Different patterns of regulation of the genes encoding the closely related 56 kDa selenium-and acetaminophen-binding proteins in normal tissues and during carcinogenesis. Carcinogenesis (Lond.), 14: 335-340, 1993.
19. Yang, M., and Sytkowski, A. J. Cloning differentially expressed genes by linker capture subtraction (LCS). Anal. Biochem., 237: 109-144, 1996.
20. Chang, P. W. G., Tsui, S. K. W., Liew, C. C., Lee, C. Y., Waye, M. M. Y., and Fung, K. P. Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell. Biochem., 64: 217-224, 1997.
21. Xie, W. Q., and Rothblum, L. I. Rapid, small-scale RNA isolation from tissue culture cells. BioTechniques, 11: 325-327, 1991.
22. Brown, S. E., and Knudson, D. L. 96-well plates for recombinant library maintenance and dot-blot production. BioTechniques, 10: 719-722, 1991.
23. Winship, P. R. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res., 17: 1266, 1989.
24. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
25. Bartolone, J. B., Birge, R. B., Bulera, S. J., Bruno, M. K., Nishanian, E. V., Cohen, S. D., and Khairallah, E. A. Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol., 113: 19-29, 1992.
26. Martin, J. L., Dubbink, D. A., Plevak, D. J., Peronne, A., Taswell, H. F., Hay, E. J., Pumford, N. R., and Pohl, L. R. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Anesth. Analg., 74: 605-608, 1992.
27. Wilson, C. M., and McPhaul, M. J. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol. Cell. Endocrinol., 120: 51-57, 1996.